» Authors » Alyce Linthurst Jones

Alyce Linthurst Jones

Explore the profile of Alyce Linthurst Jones including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 248
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Greenwald M, Namin S, Zajdowicz J, Jones A, Fritts L, Kuehnert M, et al.
Cell Tissue Bank . 2023 Nov; 25(2):583-604. PMID: 37995051
Risk for transmission of SARS-CoV-2 through allogeneic human tissue transplantation is unknown. To further evaluate the risk of virus transmission, tissues were obtained from deceased donors who had tested positive...
2.
Greenwald M, Grebe E, Green V, Jones A, Linnen J, Williamson P, et al.
Cell Tissue Bank . 2022 Dec; 24(3):585-596. PMID: 36484950
Given the possibility for disease transmission, this study was performed to determine whether there is detectable SARS-CoV-2 viral RNA in the blood of deceased tissue donors. A retrospective analysis of...
3.
Moore M, Samsell B, Wallis G, Triplett S, Chen S, Jones A, et al.
Cell Tissue Bank . 2014 Aug; 16(2):249-59. PMID: 25163609
Decellularized human dermis has been used for a number of clinical applications including wound healing, soft tissue reconstruction, and sports medicine procedures. A variety of methods exist to prepare this...
4.
Hopkins R, Jones A, Wolfinbarger L, Moore M, Bert A, Lofland G
J Thorac Cardiovasc Surg . 2009 Mar; 137(4):907-13, 913e1-4. PMID: 19327516
Objective: The juvenile sheep functional valve chronic implant calcification model was used to compare long-term calcification rates, functional performance, and durability for 3 types of right ventricular outflow tract implants:...
5.
Konig G, McAllister T, Dusserre N, Garrido S, Iyican C, Marini A, et al.
Biomaterials . 2008 Dec; 30(8):1542-50. PMID: 19111338
We have previously reported the initial clinical feasibility with our small diameter tissue engineered blood vessel (TEBV). Here we present in vitro results of the mechanical properties of the TEBVs...
6.
Ketchedjian A, Jones A, Krueger P, Robinson E, Crouch K, Wolfinbarger Jr L, et al.
Ann Thorac Surg . 2005 Mar; 79(3):888-96. PMID: 15734400
Background: Decellularized allograft tissues have been identified as a potential extracellular matrix (ECM) scaffold on which to base recellularized tissue-engineered vascular and valvular substitutes. Decreased antigenicity and the capacity to...
7.
Hilbert S, Yanagida R, Souza J, Wolfinbarger L, Jones A, Krueger P, et al.
J Heart Valve Dis . 2004 Oct; 13(5):831-40. PMID: 15473487
Background And Aim Of The Study: Biodegradable polymeric materials or extracellular matrix scaffolds are used in tissue-engineered heart valve designs, with the expectation of replicating the anatomic, histological and biomechanical...